Infinium Global Research Pre Filled Syringes Market | Page 3

Pre Filled Syringes Market: Trends and Forecast -2023 primary challenges face by this market involves manufacturing of pre filled syringes and stringent government regulations. Segment Covered The report on global pre filled syringes market covers segments such as, product type, therapeutic category and design. On the basis of product type the global pre filled syringes market is categorized into glass pre filled syringes and plastic pre filled syringes. On the basis of therapeutic category the global pre filled syringes market is categorized into insulin pre filled syringes, vaccine pre filled syringes, arthritis pre filled syringes, heparin pre filled syringes, pcsk9 inhibitor pre filled syringes and others pre filled syringes. On the basis of design the global pre filled syringes market is categorized into single-chamber prefilled syringes, dual-chamber prefilled syringes and customized prefilled syringes. Geographic Coverage The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023. Major Key Players Mentioned in this Premium Report The report provides profiles of the companies in the global pre filled syringes market such as, Becton, Dickinson and Company, Baxter International Inc, Niulife Corporation, Consort Medical plc, Ypsomed Holding AG, Nipro Corporation, West Pharmaceutical Services, Inc, SCHOTT AG, SHL Group and Haselmeier AG. 3 © Infinium Global Research